We are live on
!
Find out more
FC
Finepoint Capital Portfolio holdings
AUM
$1.95B
1-Year Est. Return
45.61%
This Fund
S&P 500
This Quarter
Est. Return
+6.54%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$51.1M
(-2.6%)
Cap. Flow
-$26M
Cap. Flow
% of AUM
-1.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
1
Reduced
2
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RXO
RXO
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QXO
QXO Inc
QXO
|
+$167M |
| 2 |
Solid Biosciences
SLDB
|
+$5.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.33% |
| 2 | Energy | 0.01% |
| 3 | Healthcare | 0% |
Similar funds
NIM
WPC
SGAM
HA
BC
FFH
NFG
MWA
Finepoint Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Finepoint Capital held 11 positions worth $1.95B, down 2.6% from $2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Finepoint Capital's Q1 2026 filing shows 2 new, 1 increased, 2 reduced and 2 closed positions. The largest sale was QXO Inc, an estimated $167M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 26% a quarter earlier, followed by Energy and Healthcare.
- Finepoint Capital added most to RXO in Q1 2026, an estimated $10.1M increase.
- Finepoint Capital's biggest Q1 2026 reduction was QXO Inc, cutting an estimated $167M.
- Finepoint Capital fully exited Solid Biosciences in Q1 2026, selling an estimated $5.42M.
- Finepoint Capital's ten largest holdings make up 100% of its $1.95B portfolio in Q1 2026.
- Finepoint Capital opened 2 new positions and closed 2 in Q1 2026.
- Finepoint Capital's portfolio value fell 2.6% quarter-over-quarter to $1.95B.
Based on Finepoint Capital's 13F filing for Q1 2026, filed 14 May 2026.